4.6 Editorial Material

Immunosurveillance of Malignant Cells with Complex Karyotypes

Journal

TRENDS IN CELL BIOLOGY
Volume 27, Issue 12, Pages 880-884

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcb.2017.09.001

Keywords

-

Categories

Funding

  1. Spanish Instituto de Salud Carlos III (FIS) [PI16/01485]
  2. Plan Nacional de I+D+I
  3. EU Fondos Feder
  4. Instituto de Salud Carlos III [PI16/01318]
  5. Plan de Ciencia, Tecnologia e Innovacion del Principado de Asturias [GRUPIN-14-030]
  6. Ligue contre le Cancer Comite de Charente-Maritime (equipe labelisee)
  7. Agence National de la Recherche (ANR)-Projets Blancs
  8. ANR under frame of E-Rare-2
  9. ERA-Net for Research on Rare Diseases
  10. Association pour la Recherche sur le Cancer (ARC)
  11. Canceropole Ile-de-France
  12. Institut National du Cancer (INCa)
  13. Inserm (HTE)
  14. Institut Universitaire de France
  15. Fondation pour la Recherche Medicale (FRM)
  16. European Commission (ArtForce)
  17. European ResearchCouncil(ERC)
  18. Fondation Carrefour
  19. LeDucq Foundation
  20. LabEx Immuno-Oncology
  21. RHU Torino Lumiere
  22. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  23. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  24. Paris Alliance of Cancer Research Institutes (PACRI)

Ask authors/readers for more resources

A wide array of cell-intrinsic surveillance mechanisms maintains the homeostasis of dividing cells and the integrity of the genome. Accumulating evidence also supports a role for cell-extrinsic mechanisms. Among them, the immune system, together with cell-autonomous checkpoint processes, eliminates cells that harbor unbalanced karyotypes generated by mitotic defects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available